Page last updated: 2024-10-30

mechlorethamine and Keratoacanthoma

mechlorethamine has been researched along with Keratoacanthoma in 2 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Keratoacanthoma: A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.

Research Excerpts

ExcerptRelevanceReference
"Despite the dramatic response of Hodgkin's disease to intensive chemotherapy, the skin lesion was rapidly transformed into squamous cell carcinoma in 10 weeks."1.26Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? ( Poleksic, S; Yeung, KY, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kopf, AW1
Bart, RS1
Poleksic, S1
Yeung, KY1

Other Studies

2 other studies available for mechlorethamine and Keratoacanthoma

ArticleYear
Development of more keratoacanthomas following skin testing with nitrogen mustard in a patient with the multiple keratoacanthoma syndrome.
    The Journal of dermatologic surgery and oncology, 1979, Volume: 5, Issue:6

    Topics: Adult; Drug Hypersensitivity; Humans; Keratoacanthoma; Male; Mechlorethamine; Skin Tests; Time Facto

1979
Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
    Cancer, 1978, Volume: 41, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Hodgkin Disease; Humans;

1978